Emergent BioSolutions Inc. (EBS)
NYSE · Healthcare
Emergent BioSolutions Inc. Cash on Hand 2009–2025
Emergent BioSolutions Inc. annual cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Emergent BioSolutions Inc. cash on hand as of December 31, 2025: 205.4M, a 106.43% increase year-over-year.
- Emergent BioSolutions Inc. cash on hand for 2025 were 205.4M, a 106.43% increase from 2024.
- Emergent BioSolutions Inc. cash on hand for 2024 were 99.5M, a 10.92% decrease from 2023.
- Emergent BioSolutions Inc. cash on hand for 2023 were 111.7M, a 82.62% decrease from 2022.
- Emergent BioSolutions Inc. cash on hand for 2022 were 642.6M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Emergent BioSolutions Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $205 |
| 2024 | $100 |
| 2023 | $112 |
| 2022 | $643 |
| 2021 | $576 |
| 2020 | $621 |
| 2019 | $168 |
| 2018 | $112 |
| 2017 | $178 |
| 2016 | $272 |
| 2015 | $313 |
| 2014 | $280 |
| 2013 | $179 |
| 2012 | $142 |
| 2011 | $144 |
Emergent BioSolutions Inc. Cash on Hand — FAQ
Emergent BioSolutions Inc. (EBS) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EBS's cash on hand history?
The chart and table above show Emergent BioSolutions Inc.'s cash on hand by year and by quarter, including the growth rate.